Physician profile
Brian C Clark
NPI 1316213234
$5,400.97
in general payments reported to CMS, 2019-2025
31 companies · $3,052 in 2025
The $3,052 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.20 · 2021: $12.81 · 2022: $597 · 2023: $839 · 2024: $813 · 2025: $3,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,704.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $1,841.88 | 2025 | Rapiblyk |
| Novartis Pharmaceuticals Corporation | $655.77 | 2019-2025 | |
| Pfizer INC. | $396.93 | 2022-2025 | |
| Boston Scientific Corporation | $302.13 | 2023-2025 | Watchman Access System, Varithena Administration Pack, Bodyguardian |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $281.90 | 2022-2025 | Lifevest |
| Novo Nordisk INC | $226.81 | 2022-2025 | Wegovy |
| Amgen INC. | $213.73 | 2022-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $207.77 | 2022-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $190.28 | 2024-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $138.19 | 2022-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.66 | 2023-2025 | Jardiance |
| Abiomed | $128.25 | 2022 | |
| Medtronic, INC. | $110.14 | 2025 | Aurora Ev-Icd Mri Surescan |
| Philips North America LLC | $77.15 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $68.44 | 2023-2025 | Farxiga, Andexxa |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $41.56 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $40.93 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $39.71 | 2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals, LTD. | $37.45 | 2022-2023 | Arcalyst |
| Heartflow, INC. | $37.31 | 2024-2025 | |
| Angiodynamics, INC. | $30.38 | 2025 | Alphavac |
| Actelion Pharmaceuticals US, INC. | $25.55 | 2023 | Opsumit |
| Abbott Laboratories | $24.87 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Lexicon Pharmaceuticals, INC. | $24.65 | 2023 | Inpefa |
| Lilly USA, LLC | $23.66 | 2025 | Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $21.09 | 2025 | |
| Impulse Dynamics (USA) INC. | $19.17 | 2023 | Optimizer |
| Regeneron Healthcare Solutions, INC. | $17.75 | 2022 | |
| Scpharmaceuticals INC. | $17.25 | 2023 | |
| Chiesi USA, INC. | $15.80 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.